John Pollack, MD
Retina Specialist · Joliet, ILNPI 1881694933
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $62,098 of the $68,206 with a category attached, or 91.0%. Notal Vision, Inc. accounts for 62.0% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $50,088 and has fallen 99.9% since, to $47 in 2025. Among retina specialist clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $1663.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Notal Vision, Inc.$42K
- Genentech, Inc.$13K
- Dutch Ophthalmic, USA$5K
- Alcon$3K
- F. Hoffmann-la Roche AG$2K
- Regeneron Healthcare Solutions, Inc.$2K
- plus $2K from 9 others
Across 28 payments — averaging $11,809 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$331K
What the payments were for
- Consulting fees$62,09891%
- Speaking & faculty fees$4,7217%
- Food & beverage$1,2932%
- Education$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Notal Vision, Inc. | 6 | $42,300 |
| Genentech, Inc. | 3 | $12,560 |
| Dutch Ophthalmic, USA | 1 | $4,500 |
| Alcon | 1 | $2,500 |
| F. Hoffmann-la Roche AG | 2 | $2,221 |
| Regeneron Healthcare Solutions, Inc. | 5 | $1,887 |
| AbbVie(2 entities) | 9 | $1,258 |
| Carl Zeiss Meditec, Inc. | 2 | $624 |
| Genentech USA, Inc. | 6 | $178 |
| Apellis Pharmaceuticals, Inc. | 1 | $78 |
| Amgen | 1 | $25 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
| Heidelberg Engineering, Inc. | 1 | $19 |
| Coherus Oncology, Inc. | 1 | $18 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ForeseeHome$42,300
- EVA Ophthalmic Surgical System$4,500
- Lucentis$2,221
- EYLEA$1,738
- OZURDEX$165
How this compares
$68,206 in reported general payments places this provider in the 90th percentile of 70 retina specialist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 15 | $835 |
| Latanoprost | 26 | $287 |
| Ciprofloxacin Hcl | 11 | $177 |
| Ketorolac Tromethamine | 13 | $144 |
| Timolol Maleate | 17 | $142 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Joliet
- Mathew MaccumberHarvey$219K
- Rahul KomatiChicago$143K
- Kourous RezaeiHarvey$126K
- Kirk PackoHarvey$86K
- David OrthHarvey$70K
- Veena RaijiChicago$69K
- Timothy FloodHarvey$57K
- Brian LarsenLombard$38K
- Serge DebustrosHarvey$34K
- Vivek ChaturvediHarvey$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.